menu
    • menu

    Company profile for Quince Therapeutics

    NEW Drugs in Dev: 8
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Quince Therapeutics is focused on advancing innovative precision therapeutics targeting debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote more rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Quince’s discov...
    Quince Therapeutics is focused on advancing innovative precision therapeutics targeting debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote more rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Quince’s discovery pipeline is positioned for rapid expansion across multiple skeletal therapeutic indications to address underserved therapeutic areas.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quince TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    601 Gateway Blvd, Suite 1250, South San Francisco, California 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quincetx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quincetx-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quince Therapeutics Shows Positive Phase 2 Data in PAH and PH-ILD
    Quince Therapeutics Shows Positive Phase 2 Data in PAH and PH-ILD

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296719/0/en/quince-therapeutics-announces-clinically-meaningful-improvements-across-functional-hemodynamic-and-biomarker-measures-in-phase-2-study-in-pah-and-ph-ild.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Quince Acquires Orphai, Secures $187M for Pulmonary Pipeline
    Quince Acquires Orphai, Secures $187M for Pulmonary Pipeline

    18 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/18/3296720/0/en/quince-announces-acquisition-of-orphai-and-up-to-187-million-private-placement-to-advance-pulmonary-pipeline.html

    GLOBENEWSWIRE
    18 May 2026
    Share Share
    Quince Therapeutics Settles Approximately $16.4 Million of Debt
    Quince Therapeutics Settles Approximately $16.4 Million of Debt

    30 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260330442673/en/Quince-Therapeutics-Settles-Approximately-%2416.4-Million-of-Debt

    BUSINESSWIRE
    30 Mar 2026
    Share Share
    Quince Pharma Hires Lifesci Capital For Strategic Options
    Quince Pharma Hires Lifesci Capital For Strategic Options

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260209949613/en/Quince-Therapeutics-Engages-LifeSci-Capital-as-its-Exclusive-Financial-Advisor-to-Explore-Strategic-Alternatives

    BUSINESSWIRE
    09 Feb 2026
    Share Share
    Quince Reports Positive Ph 3 eDSP Data in Ataxia-Telangiectasia
    Quince Reports Positive Ph 3 eDSP Data in Ataxia-Telangiectasia

    29 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260129349326/en/Quince-Therapeutics-Announces-Topline-Results-from-Pivotal-Phase-3-NEAT-Clinical-Trial-of-eDSP-in-Ataxia-Telangiectasia

    BUSINESSWIRE
    29 Jan 2026
    Share Share
    Quince Therapeutics Reveals Long-Term eDSP Safety Data
    Quince Therapeutics Reveals Long-Term eDSP Safety Data

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128605412/en/Quince-Therapeutics-Presents-Safety-Data-from-Long-Term-eDSP-Treatment-in-Children-with-Ataxia-Telangiectasia-at-British-Paediatric-Neurology-Association-Annual-Meeting

    BUSINESSWIRE
    28 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search